CIRB Studies

Below is the current list of studies covered by the CIRB. It includes both Available to Open and Completed studies. Study documents approved after July 1, 2013 for all covered studies are available on the CTSU website.

To request documents approved before July 1, 2013, please contact the CIRB Helpdesk.

Displaying 21 - 30 of 820
Study Number Lead Group Study Title CIRB Study Status
UAZ2016-08-02 CLO-University of Arizona A feasibility trial of alternating intravaginal application of 5-fluorouracil and imiquimod for treatment of high-grade cervical squamous intraepithelial lesions Cancer Prevention and Control CIRB Available to Open
UAZ2015-05-02 CLO-University of Arizona M4OC-Prevent: Metformin for Oral Cancer Prevention Cancer Prevention and Control CIRB Available to Open
UAZ2015-05-01 CLO-University of Arizona A prospective, single-arm, open-label, non-randomized, phase IIA trial of a nonavalent prophylactic HPV vaccine to assess immunogenicity of a prime and deferred-booster dosing schedule among 9-11 year-old girls and boys Cancer Prevention and Control CIRB Available to Open
SWOG-9007 SWOG Cytogenetic Studies in Leukemia Patients Adult CIRB - Late Phase Emphasis Completed
SCUSF-0901 COG SCUSF 0901 [ACCL0922] A Phase II Placebo-Controlled Trial of Modafinil to Improve Neurocognitive Deficits in Children Treated for a Primary Brain Tumor Pediatric CIRB Available to Open
S9925 SWOG Lung Cancer Specimen Repository Protocol Ancillary Adult CIRB - Late Phase Emphasis Completed
S9910 SWOG Leukemia Centralized Reference Laboratories and Tissue Repositories Ancillary Adult CIRB - Late Phase Emphasis Completed
S1933 SWOG A Pilot Study of Hypofractionated Radiotherapy Followed by Atezolizumab Consolidation in Stage II or III NSCLC Patients with Borderline Performance Status Adult CIRB - Late Phase Emphasis Available to Open
S1922 SWOG Randomized Phase II Selection Study of Ramucirumab and Paclitaxel Versus FOLFIRI In Refractory Small Bowel Adenocarcinoma Adult CIRB - Late Phase Emphasis Available to Open
S1914 SWOG A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT versus SBRT Alone in High Risk, Early Stage NSCLC Adult CIRB - Late Phase Emphasis Available to Open
Displaying 21 - 30 of 820